Citalopram and Cannabidiol: In Vitro and In Vivo Evidence of Pharmacokinetic Interactions Relevant to the Treatment of Anxiety Disorders in Young People
Conclusions
Further pharmacokinetic examination of the interaction between CBD and citalopram/escitalopram is clearly warranted, and clinicians should be vigilant around the possibility of treatment-emergent adverse effects when CBD is introduced to patients taking these antidepressants.
Source: Journal of Clinical Psychopharmacology - Category: Psychiatry Tags: Original Contributions Source Type: research
More News: Anxiety | Celexa | Citalopram | Clinical Trials | Epilepsy | Fluoxetine | Lexapro | Mirtazapine | Prozac | Psychiatry | Sertraline | Study | Zoloft